Stock Events

Stock Events

ElectroCore 

€0.000000
0
+€0.00+0% 00:00 Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

12AugExpected
Q1 2026
Next
-0.52
-0.47
-0.42
-0.36
Expected EPS
-0.3624777
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 43E.STU. It's not an investment recommendation.
Apple
12
AAPL
Tesla
12
TSLA
Microsoft
11
MSFT
Amazon
11
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
LivaNova
LIVN
Mkt Cap4.59B
LivaNova PLC operates in the same space of neuromodulation, providing therapies that could directly compete with ElectroCore's solutions for epilepsy and other neurological conditions.
Inspire Medical Systems
INSP
Mkt Cap1.35B
Inspire Medical Systems, Inc. offers innovative obstructive sleep apnea treatments using nerve stimulation, a direct competitor to ElectroCore's nerve stimulation therapies.
Neogen
NEOG
Mkt Cap2.07B
Neogen Corporation, while primarily focused on food and animal safety, has divisions that explore bioelectronic medicine, potentially overlapping with ElectroCore's market.
Boston Scientific
BSX
Mkt Cap67.09B
Boston Scientific Corporation offers a wide range of medical devices, including neuromodulation products that could serve as alternatives to ElectroCore's technology.
Abbvie
ABBV
Mkt Cap461.26B
AbbVie Inc., through its acquisition of Allergan, has entered the neuromodulation market, potentially competing with ElectroCore's offerings.
Medtronic
MDT
Mkt Cap106.49B
Medtronic PLC provides a broad array of medical devices, including those for neuromodulation, directly competing with ElectroCore's nerve stimulation devices.
Smith & Nephew
SNN
Mkt Cap12.78B
Smith & Nephew plc, while mainly focused on orthopedics, has started exploring the bioelectronic medicine space, which could put it in competition with ElectroCore.
Stryker
SYK
Mkt Cap125.18B
Stryker Corporation's medical technologies, including neurotechnology and spine products, could indirectly compete with ElectroCore by offering different solutions for similar conditions.

About

electroCore, Inc. is a commercial-phase medical device enterprise whose focus lies in developing and bringing to market a variety of non-invasive vagus nerve stimulation (nVNS) therapies. Currently, the firm is advancing gammaCore, a prescription-only nVNS therapy specifically engineered for adults to acutely treat the discomfort associated with both migraine and episodic cluster headaches. Its flagship offering, the gammaCore Sapphire, is a portable, rechargeable, and refillable device intended for either regular or intermittent use over many years. Established in 2005, its corporate headquarters are situated in Rockaway, New Jersey.
Show more...
CEO
ISIN
US28531P1030

Listings

STU
DE
43E0.STU
XNAS
US
ECOR
STU
DE
43E.STU
MU
DE
43E0.MU

0 Comments

Share your thoughts

FAQ

What is ElectroCore stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange ElectroCore stocks are traded under the ticker 43E.STU.
When is the next ElectroCore earnings date?▼
ElectroCore is going to release the next earnings report on August 12, 2026.
What were ElectroCore earnings last quarter?▼
43E.STU earnings for the last quarter are -0.5 EUR per share, whereas the estimation was -0.52 EUR resulting in a +3.59% surprise. The estimated earnings for the next quarter are N/A EUR per share.
In which sector is ElectroCore located?▼
ElectroCore operates in the Other sector.
When did ElectroCore complete a stock split?▼
ElectroCore has not had any recent stock splits.